Collaboration - June 21, 2021
SAGA Diagnostics expands research collaboration
The company has announced an expanded research collaboration with Professor Charles Swanton, at the University College London (UCL) Cancer Institute. Last year, SAGA and UCL entered into a research collaboration on a limited number of patients. With the newly signed agreement, SAGA will utilize its SAGAsafe assays for detection of a panel of mutations in […]
Collaboration - June 16, 2021
Pilloxa enters new collaboration
Pilloxa has announced that it is to collaborate with the Nordic office of Chiesi Global Rare Diseases on using the company’s platform to support the treatment journey for patients with nephropathic cystinosis across Scandinavia. “We are honored to work with the Nordic office of Chiesi Global Rare Diseases to support patients, an incredible partner within […]
Collaboration - June 2, 2021
SciLifeLab enters new collaboration with EMBL
SciLifeLab and The European Molecular Biology Laboratory (EMBL) will intensify collaboration between the two organizations under the joint Memorandum of Understanding (MoU). The MoU declares a joint ambition to stimulate mutually beneficial scientific and academic exchange and collaboration in various areas of life science research in order to ensure greater connectivity, availability of scientific data, […]
Collaboration - May 27, 2021
OnDosis expands collaboration with Tiefenbacher Group
OnDosis and German B2B pharmaceutical company Tiefenbacher Group initiate four new development projects targeting ADHD, rare diseases and transplantation medicine. Last year, the two companies began cooperating on an ADHD treatment that has already received attention in the USA, states the company in a press release. “Whilst our first ADHD project fast approaches final stages […]
Collaboration - May 27, 2021
Nanoform and Celanese announce plans to collaborate
Nanoform and Celanese Corporation have announced plans to explore the synergies between their respective technologies in the field of nanoparticle-enabled drug delivery. The goal is to assess the utility of combining Nanoform’s nanoparticle platform technologies with Celanese’s VitalDose EVA copolymer delivery technology for drug-eluting implants, states Nanoform in a press release. The aims are to […]
Collaboration - May 25, 2021
LINK Medical and Medaffcon collaborate
LINK Medical and Medaffcon have announced their collaboration to provide customers with integrated, full-service Real World Evidence (RWE) and Market Access support across all Nordic countries. “We are excited to collaborate with LINK Medical and expand our RWE services across the Nordics, facilitating our customers with local knowledge and expertise. Through this collaboration we are […]